Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Reviewing Trends in Stability Studies – V 2.0

Posted on By

SOP for Reviewing Trends in Stability Studies – V 2.0

Procedure for Reviewing Trends in Stability Studies

Department Quality Control (QC)/Quality Assurance (QA)/Research & Development (R&D)
SOP No. SOP/Ointment/108
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic process for reviewing trends in stability studies of ointments. This ensures timely identification of potential stability concerns, compliance with regulatory requirements, and continuous product quality improvement.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Research & Development (R&D) departments responsible for analyzing and interpreting stability study trends.

3. Responsibilities

  • QC Analyst: Records and compiles stability test results at predefined intervals.
  • QC Supervisor: Reviews stability trends and ensures data accuracy.
  • QA Officer: Verifies trend analysis and investigates any deviations.
  • R&D Scientist: Evaluates trends to suggest formulation improvements if required.
  • QA Manager: Approves trend analysis reports and ensures regulatory compliance.
See also  Ointments: SOP for Preparing Stability Study Protocols - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring that stability trend analyses comply with ICH Q1A(R2) guidelines and that corrective actions are implemented when necessary.

5. Procedure

5.1 Data Collection for Trend Analysis

  • Compile stability test data from multiple batches over different time points.
  • Ensure that data includes all testing parameters such as:
    • Physical
properties (color, texture, phase separation)
  • Chemical properties (assay, degradation products)
  • Microbiological testing (contamination levels)
  • pH variation
  • Viscosity changes
  • Maintain electronic and physical records for ease of retrieval and comparison.
  • 5.2 Statistical Analysis and Trend Identification

    • Use statistical tools such as standard deviation, mean, and trend graphs to analyze data.
    • Compare results across different storage conditions (e.g., long-term, intermediate, accelerated stability).
    • Identify any recurring deviations or out-of-trend (OOT) results.

    5.3 Handling Out-of-Trend (OOT) Results

    • Investigate any anomalies or unexpected deviations in stability trends.
    • Document OOT observations and conduct root cause analysis.
    • Determine if corrective and preventive actions (CAPA) are required.

    5.4 Reporting and Approval

    • Prepare a Stability Trend Report summarizing findings.
    • Ensure review and approval by QA and R&D before submission to regulatory authorities.
    • Use trend data to make formulation improvements or modify storage recommendations.

    5.5 Periodic Review and Continuous Improvement

    • Conduct quarterly or annual reviews of stability trends.
    • Use past trends to predict long-term product stability behavior.
    • Update stability study protocols based on emerging trends and new regulatory guidelines.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • ICH – International Council for Harmonisation
    • OOT – Out-of-Trend
    • CAPA – Corrective and Preventive Action

    7. Documents

    • Stability Trend Analysis Report (Annexure-1)
    • OOT Investigation Report (Annexure-2)

    8. References

    • ICH Q1A(R2) Stability Testing of New Drug Substances and Products
    • WHO GMP Guidelines for Pharmaceutical Stability Studies

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Stability Trend Analysis Report

    Batch Number Testing Interval Parameter Observed Trend Reviewed By
    OINT-801 6 Months Viscosity Stable QA Officer
    OINT-802 12 Months pH Slight Decrease QA Officer

    Annexure-2: OOT Investigation Report

    Batch Number Observed Issue Potential Cause Corrective Action Final Decision
    OINT-803 pH Drop Below Limit Excipient Degradation Reformulation Approved
    OINT-804 Phase Separation Storage Condition Variability Storage Recommendations Updated Approved

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    See also  Ointments: SOP for Recording and Investigating Non-Conformance Reports - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Capsule: SOP for Receiving Raw Materials for Capsule Manufacturing – V 2.0
    Next Post: Capsule: SOP for Sampling Raw Materials for Quality Testing – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version